RARE Cancers Australia has today launched a new report developed by PwC which urges the government, industry and research community to unite to improve access and outcomes for Australian patients suffering rare cancers.
Dubbed Rare Solutions: A Time to Act the report tables solutions including clinical trial reform to support TGA registrations and PBS listings from the outset.
It also urges "provisional PBS listings" which would mitigate delays in access to treatment due to requirements for real-world evidence.
More info at rarecancers.org.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Aug 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Aug 17